Dan Victor

Key Points Despite a recent rally, Roblox shares remain well below their all-time high. The company is benefiting from a growth resurgence and record user engagement. The stock could soar in 2025 as the company inches toward sustained profitability. Motley Fool Issues Rare “All In” Buy Alert

Key Points Shares of Altria are benefiting from an improved growth and earnings outlook. The company is seeing strong demand for its smoke-free products including NJOY e-cigarettes and ON! brand nicotine pouches. A 7% dividend yield makes Altria stock a compelling high-yield income opportunity. Motley Fool Issues Rare “All In” Buy Alert

Key Points Shares of online broker Robinhood have rallied to their highest level since 2021. The company is benefiting from a strong rebound in trading activity and demand for its broader ecosystem of financial services. The company's ability to continue generating profitable growth will be key for the stock into 2025.

In This Article UPS Key Questions Is UPS still a good investment opportunity despite its recent underperformance?

Key Points Shares of CRISPR Therapeutics have struggled amid less-than-stellar sales of its Casgevy therapy. The company's gene-editing biotechnology holds much promise but still faces significant uncertainties. The market will be closely watching clinical readouts for the company's drug candidate portfolio in 2025. Motley Fool Issues Rare “All In” Buy Alert

Key Points The First Trust RBA American Industrial Renaissance ETF invests in U.S. companies that primarily generate sales domestically. U.S. manufacturers could benefit from proposed foreign capital goods tariffs under the incoming Trump administration. The AIRR ETF may be a good option for investors to gain exposure to small- and mid-cap industrial stocks. Motley Fool Issues Rare “All In” Buy Alert

Key Points Strong earnings have helped Walmart shares, while weak growth has pressured Target stock. A resilient economic environment supports a positive outlook for retailers going forward. One of these retail giants may offer better value for investors heading into 2025. 10 stocks we like better than Target

Key Points DraftKings is generating fantastic growth amid the explosive popularity of online gambling and sports betting. The company expects to launch its sportsbook in Missouri in 2025 as the latest state to legalize and regulate the activity. An outlook for strong earnings momentum could be a catalyst for the stock to rally higher. Motley Fool Issues Rare “All In” Buy Alert

Key Points Recursion is using artificial intelligence and machine learning to accelerate drug research and development. The company benefits from partnerships with major tech and healthcare leaders, reaffirming its potential. Updates from an extensive pipeline of drug candidates could propel the stock higher in 2025. Motley Fool Issues Rare “All In” Buy Alert

Successfully navigating the stock market requires patience and a long-term perspective. Recursion Pharmaceuticals (NASDAQ: RXRX) is a clinical-stage biotech that may have that level of potential. The company harnesses artificial intelligence (AI) for drug discovery, promising to revolutionize medicine.